Bryan W. Sherman

471 total citations
11 papers, 369 citations indexed

About

Bryan W. Sherman is a scholar working on Molecular Biology, Pharmacology and Ophthalmology. According to data from OpenAlex, Bryan W. Sherman has authored 11 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Pharmacology and 4 papers in Ophthalmology. Recurrent topics in Bryan W. Sherman's work include Receptor Mechanisms and Signaling (5 papers), Flavonoids in Medical Research (4 papers) and Glaucoma and retinal disorders (4 papers). Bryan W. Sherman is often cited by papers focused on Receptor Mechanisms and Signaling (5 papers), Flavonoids in Medical Research (4 papers) and Glaucoma and retinal disorders (4 papers). Bryan W. Sherman collaborates with scholars based in United States and Taiwan. Bryan W. Sherman's co-authors include Mitchell A. deLong, Casey Kopczynski, Carmen Laethem, Cheng‐Wen Lin, Ponugoti Vasantha Rao, Da‐Wen Lu, Padmanabhan P. Pattabiraman, Jeffrey D. Yingling, Geoffrey R. Heintzelman and David N. Deaton and has published in prestigious journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters and Journal of Ocular Pharmacology and Therapeutics.

In The Last Decade

Bryan W. Sherman

11 papers receiving 359 citations

Peers

Countries citing papers authored by Bryan W. Sherman

Since Specialization

Citations

This map shows the geographic impact of Bryan W. Sherman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan W. Sherman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan W. Sherman more than expected).

Fields of papers citing papers by Bryan W. Sherman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bryan W. Sherman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan W. Sherman. The network helps show where Bryan W. Sherman may publish in the future.

Co-authorship network of co-authors of Bryan W. Sherman

This figure shows the co-authorship network connecting the top 25 collaborators of Bryan W. Sherman. A scholar is included among the top collaborators of Bryan W. Sherman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bryan W. Sherman. Bryan W. Sherman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Discovery and Preclinical Development of Netarsudil, a Novel Ocular Hypotensive Agent for the Treatment of Glaucoma 2017 ·Journal of Ocular Pharmacology and Therapeutics ·Cheng‐Wen Lin, Bryan W. Sherman, (unknown), Carmen Laethem, Da‐Wen Lu, Padmanabhan P. Pattabiraman, Ponugoti Vasantha Rao, Mitchell A. deLong, Casey Kopczynski	132
2	Discovery of the ROCK inhibitor netarsudil for the treatment of open-angle glaucoma 2016 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), Cheng‐Wen Lin, (unknown), Jeffrey D. Yingling, Carmen Laethem, Bryan W. Sherman, Geoffrey R. Heintzelman, Casey Kopczynski, Mitchell A. deLong	82
3	IOP-lowering Efficacy And Tolerability Of AR-13324, A Dual Mechanism Kinase Inhibitor For The Treatment Of Glaucoma 2012 ·Casey Kopczynski, Cheng‐Wen Lin, Mitchell A. deLong, Jeffrey D. Yingling, (unknown), (unknown), Bryan W. Sherman, Carmen Laethem, (unknown)	3
4	Discovery and SAR of a Class of Ocularly-active Compounds Displaying a Dual Mechanism of Activity for the Treatment of Glaucoma 2012 ·Mitchell A. deLong, (unknown), Cheng‐Wen Lin, Bryan W. Sherman, (unknown), (unknown), (unknown), (unknown), Casey Kopczynski	5
5	Discovery and in vitro SAR of AR-12286, a Potent Kinase Inhibitor for the Treatment of Glaucoma 2009 ·Mitchell A. deLong, (unknown), (unknown), (unknown), Jeffrey D. Yingling, Carmen Laethem, Bryan W. Sherman, Casey Kopczynski	8
6	Synthesis and evaluation of potent and selective β3 adrenergic receptor agonists containing heterobiaryl carboxylic acids 2007 ·Bioorganic & Medicinal Chemistry Letters ·Barry G. Shearer, Esther Y. Chao, David Uehling, David N. Deaton, Conrad L. Cowan, Bryan W. Sherman, (unknown), (unknown), Kathleen K. Brown, Kimberly K. Adkison, Frank Lee	15
7	Biarylaniline Phenethanolamines as Potent and Selective β₃Adrenergic Receptor Agonists 2006 ·Journal of Medicinal Chemistry ·David Uehling, Barry G. Shearer, (unknown), Esther Y. Chao, David N. Deaton, (unknown), Kathleen K. Brown, Neal F. Cariello, (unknown), Mary E. Lancaster, Jasmine Lin, Robert W. Hart, (unknown), Mark Paulik, Bryan W. Sherman, Elizabeth E. Sugg, Conrad L. Cowan	33
8	2-(Anilinomethyl)imidazolines as α1 adrenergic receptor agonists: α1a subtype selective 2′-heteroaryl compounds 2003 ·Bioorganic & Medicinal Chemistry Letters ·Jason D. Speake, Frank Navas, Michael J. Bishop, (unknown), Eric C. Bigham, (unknown), David L. Saussy, (unknown), (unknown), Bryan W. Sherman	15
9	α1-Adrenoceptor activation: A comparison of 4-(Anilinomethyl)imidazoles and 4-(Phenoxymethyl)imidazoles to related 2-imidazolines 2002 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Eric C. Bigham, (unknown), (unknown), (unknown), James A. Liacos, Frank Navas, David L. Saussy, Bryan W. Sherman, Jason D. Speake, Michael J. Bishop	4
10	2-(Anilinomethyl)imidazolines as α₁ Adrenergic Receptor Agonists: the Discovery of α₁_a Subtype Selective 2‘-Alkylsulfonyl-Substituted Analogues 2002 ·Journal of Medicinal Chemistry ·(unknown), Michael J. Bishop, Jason D. Speake, Frank Navas, (unknown), Eric C. Bigham, David L. Saussy, James A. Liacos, (unknown), (unknown), Bryan W. Sherman	24
11	Synthesis and Evaluation of Potent and Selective β₃ Adrenergic Receptor Agonists Containing Acylsulfonamide, Sulfonylsulfonamide, and Sulfonylurea Carboxylic Acid Isosteres 2001 ·Journal of Medicinal Chemistry ·David Uehling, (unknown), David N. Deaton, (unknown), Elizabeth E. Sugg, David G. Barrett, Robert G. Hughes, (unknown), (unknown), Mary E. Lancaster, Frank Lee, Robert W. Hart, Mark Paulik, Bryan W. Sherman, Timothy A. True, Conrad L. Cowan	48

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact